A detailed history of Aqr Capital Management LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 12,230 shares of IGMS stock, worth $211,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,230
Holding current value
$211,089
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.51 - $11.47 $79,617 - $140,278
12,230 New
12,230 $84,000
Q2 2021

Aug 16, 2021

SELL
$57.98 - $96.6 $166,692 - $277,725
-2,875 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$71.56 - $121.23 $205,735 - $348,536
2,875 New
2,875 $220,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.